Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Advanced Therapies
Filter
Filter
Sort By
Newest First
1 / 28
Sector
Modality / Product
Service / Activity
Reset
Cell Therapy
Expanding the Frontiers of Cell Therapy: Veterinary Applications and Translational Insights
April Stanley, MS MBA; Sophie Lutter, Ph.D.
Nice Insight
PAO-03-25-NI-07
Mar 26, 2025
RNA
Is mRNA a Gene Therapy? Unpacking the Evolving Regulatory Debate
Cynthia A. Challener, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
PAO-03-25-NI-06
Mar 26, 2025
RNA
What new opportunities are emerging for mRNA technology, and how is the portfolio of applications expanding beyond vaccines?
Pharma's Almanac
PAO-03-25-RT-02
Mar 26, 2025
OMVs and EVs
Driving Therapeutic Innovation with OMVs and EVs
Ola Tuvesson; Isa Lindgren, Ph.D.
NorthX Biologics
PAO-02-25-CL-09
Mar 21, 2025
RNA
Beyond mRNA Vaccines: The Expanding World of RNA-Based Therapeutics
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-24
Mar 21, 2025
Aging
Resetting the Biological Clock: OKSM and the Reversal of Aging
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-22
Mar 19, 2025
LOGIC GATES
Boolean Biology: The Future of Logic-Gated Cell and Gene Therapies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-03-25-NI-03
Mar 14, 2025
HTS
The High-Throughput Screening Transformation in Modern Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-12
Mar 02, 2025
Immuno-oncology
Immuno-Oncology at the Forefront of Cancer Medicine
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-10
Mar 02, 2025
Small Biotechs
Five Small Biotechs to Watch: March 2025
David Alvaro, Ph.D.
Pharma's Almanac
PAO-02-25-NI-06
Feb 28, 2025
Radioconjugates
Rising Interest in Radioconjugate Therapies
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-02-25-NI-05
Feb 25, 2025
Approval
Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial
Anixa Biosciences
PR-02-25-NI-16
Feb 19, 2025
Gene Therapy
Genprex Provides Update on Diabetes Gene Therapy Program
Genprex
PR-02-25-NI-15
Feb 19, 2025
xRNA
Revolutionizing xRNA Production: The Economic Case for Continuous Manufacturing
Aaron B. Cowley, Ph.D.
ReciBioPharm
PAO-02-25-CL-11
Feb 13, 2025
Clinical Trials
EXUMA Biotech Announces Phase 1 Results for its Autologous HER2 Directed CAR-T Product at ASCO GI 2025
EXUMA Biotechnology
PR-01-25-NI-26
Feb 11, 2025
Clinical Trials
CARsgen's First Enrolled Subject in the THANK-u Plus™ Platform-Based Allogeneic CAR-T Trial Achieves sCR at Week 4
Carsgen Therapeutics
PR-02-25-NI-09
Feb 11, 2025
RNA
Enabling Cost-Effective, Rapid Access to RNA Vaccines and Therapeutics with Enzymatically Generated z- dbDNA
Lisa Caproni
Touchlight
PAO-01-25-CL-08
Feb 10, 2025
Cell Therapy
From Research to Clinical Trials to Commercialization: Advancing CGT with Frozen Cellular Starting Materials
Dominic Mancini
OrganaBio
PAO-01-25-CL-13
Jan 28, 2025
Advanced Therapies
Ensuring Nuclease Free Process Consumables for Biopharma Applications
Richard Fry
Sanisure
PAO-01-25-CL-05
Jan 22, 2025
Protein Portfolio
Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine
Bio-Techne Corporation
PR-01-25-NI-05
Jan 10, 2025
1 / 28
